A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Fluoxymesterone
Perphenazine enanthate
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Perphenazine enanthate.
Fluoxymesterone
Dixyrazine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Dixyrazine.
Fluoxymesterone
Thiazinam
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Thiazinam.
Fluoxymesterone
Chlorproethazine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Chlorproethazine.
Fluoxymesterone
Butaperazine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Butaperazine.
Fluoxymesterone
Perazine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Perazine.
Fluoxymesterone
Propiopromazine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Propiopromazine.
Fluoxymesterone
Methylene blue
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Methylene blue.
Fluoxymesterone
Cyamemazine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Cyamemazine.
Fluoxymesterone
BL-1020
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with BL-1020.
Fluoxymesterone
Thioproperazine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Thioproperazine.
Fluoxymesterone
Aceprometazine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Aceprometazine.
Fluoxymesterone
Acepromazine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Acepromazine.
Fluoxymesterone
Periciazine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Periciazine.
Fluoxymesterone
Methotrimeprazine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Methotrimeprazine.
Fluoxymesterone
Alimemazine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Alimemazine.
Fluoxymesterone
Lumefantrine
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Lumefantrine.
Fluoxymesterone
Artemether
The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Artemether.
Ifosfamide
Satralizumab
The serum concentration of Apixaban can be decreased when it is combined with Satralizumab.
Ifosfamide
Abametapir
The serum concentration of Apixaban can be increased when it is combined with Abametapir.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3